183 related articles for article (PubMed ID: 5638661)
1. Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-dopa: correlation of behavioral and biochemical differences in two strains of mice.
Seiden LS; Peterson DD
J Pharmacol Exp Ther; 1968 Feb; 159(2):422-8. PubMed ID: 5638661
[No Abstract] [Full Text] [Related]
2. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
Seiden LS; Peterson DD
J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
[No Abstract] [Full Text] [Related]
3. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
Boggan WO; Seiden LS
Physiol Behav; 1971 Mar; 6(3):215-7. PubMed ID: 5125476
[No Abstract] [Full Text] [Related]
4. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
Lotti VJ; Porter CC
J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
[No Abstract] [Full Text] [Related]
5. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
Ahlenius S
Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
[No Abstract] [Full Text] [Related]
6. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
Ahlenius S; Engel J
Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
[No Abstract] [Full Text] [Related]
7. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
Uretsky NJ; Seiden LS
J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
[No Abstract] [Full Text] [Related]
8. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
Seiden LS; Martin TW
Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
[No Abstract] [Full Text] [Related]
9. The occurrence of biogenic monoamines in the mammalian endocrine pancreas.
Cegrell L
Acta Physiol Scand Suppl; 1968; 314():1-60. PubMed ID: 4973243
[No Abstract] [Full Text] [Related]
10. [Effect of catecholamines on the central nervous system. (1). Role of dopamine in the brain in animal behavioral changes].
Kameyama T; Kisara K
Nihon Yakurigaku Zasshi; 1966 Sep; 62(5):317-26. PubMed ID: 5298294
[No Abstract] [Full Text] [Related]
11. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
Butcher LL; Rhodes DL; Yuwiler A
Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
[No Abstract] [Full Text] [Related]
12. Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA.
Seiden LS; Hanson LC
Psychopharmacologia; 1964 Oct; 6(4):239-44. PubMed ID: 5830803
[No Abstract] [Full Text] [Related]
13. The effect of L-DOPA on brain catecholamines and motility in rats.
Maj J; Grabowska M; Mogilnicka E
Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
[No Abstract] [Full Text] [Related]
14. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
Butcher LL; Engel J
Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
[No Abstract] [Full Text] [Related]
15. Aromatic amino acid decarboxylase inhibitors.
Porter CC
Fed Proc; 1971; 30(3):871-6. PubMed ID: 5575298
[No Abstract] [Full Text] [Related]
16. Biochemical and behavioral effects of l-DOPA methyl ester in cats treated with reserpine.
Hanson LC; Utley JD
Psychopharmacologia; 1965 Jul; 8(2):140-4. PubMed ID: 5853737
[No Abstract] [Full Text] [Related]
17. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
Ng LK; Colburn RW; Kopin IJ
J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
[No Abstract] [Full Text] [Related]
18. Inhibition of DOPA accumulation by rat brain at critical L-DOPA circulating concentrations.
Horst WD; Bautz G; Renyi E; Spirt N
Adv Neurol; 1974; 5():369-73. PubMed ID: 4440584
[No Abstract] [Full Text] [Related]
19. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
Maj J; Pawlowski L; Sarnek J
Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
[No Abstract] [Full Text] [Related]
20. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
Bartholini G; Pletscher A
J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
